文献速递神经肿瘤

髓系相关基因的胚系多态性与胶质瘤患者生存无关

Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.
PubMed 文献 · J Neurooncol · 2017-09-30

研究纳入1992至2008年在德克萨斯大学MD安德森癌症中心治疗的992例胶质瘤患者,分析91个髓系相关基因的单核苷酸多态性与生存的关联。在多变量校正后,胶质母细胞瘤中无基因变异与生存显著相关;低级别胶质瘤中CD163的rs147960238(p=2.2×10-5)和MET的rs17138945(p=5.6×10-5)与生存显著相关,但未在563例独立低级别胶质瘤病例中验证。结果不支持髓系相关基因的遗传多态性影响胶质瘤患者生存。

要点

  • 在胶质母细胞瘤中,经多重检验校正后,无髓系相关基因变异与生存显著相关。
  • 低级别胶质瘤中CD163 rs147960238和MET rs17138945与生存显著相关,但独立分析未验证。
  • 结果不支持髓系相关基因的胚系多态性影响胶质瘤患者生存。

核心结论

  • 研究结果不支持髓系相关基因的遗传多态性影响胶质母细胞瘤或低级别胶质瘤患者的生存。

研究设计与样本

  • 研究纳入1992至2008年在德克萨斯大学MD安德森癌症中心治疗的992例胶质瘤患者,其中胶质母细胞瘤(WHO IV级)511例,低级别胶质瘤(WHO II-III级)481例。
  • 对91个髓系相关基因的单核苷酸多态性(SNP)采用Cox回归分析其与生存的关联,分别在胶质母细胞瘤和低级别胶质瘤组中进行个体SNP和基因水平的检验。
  • 验证队列为加利福尼亚大学旧金山分校成人胶质瘤研究的563例低级别胶质瘤病例。

主要发现

  • 经多重检验校正后,胶质母细胞瘤中无髓系相关基因变异与生存显著相关。
  • 低级别胶质瘤中,CD163的rs147960238(p=2.2×10-5)和MET的rs17138945(p=5.6×10-5)与生存显著相关。
  • 上述两个SNP在563例独立低级别胶质瘤病例中未获验证(p=0.65和p=0.41)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune cells of myeloid origin, including microglia, macrophages, and myeloid-derived suppressor cells adopt immunosuppressive phenotypes that support gliomagenesis. Here, we tested an a priori hypothesis that single nucleotide polymorphisms (SNPs) in genes related to glioma-associated myeloid cell regulation and function are also associated with patient survival after glioma diagnosis. Subjects for this study were 992 glioma patients treated at The University of Texas MD Anderson Cancer Center in Houston, Texas between 1992 and 2008. Haplotype-tagging SNPs in 91 myeloid-associated genes were analyzed for association with survival by Cox regression. Individual SNP- and gene-based tests were performed separately in glioblastoma (WHO grade IV, n = 511) and lower-grade glioma (WHO grade II-III, n = 481) groups. After adjustment for multiple testing, no myeloid-associated gene variants were significantly associated with survival in glioblastoma. Two SNPs, rs147960238 in CD163 (p = 2.2 × 10-5) and rs17138945 in MET (p = 5.6 × 10-5) were significantly associated with survival of patients with lower-grade glioma. However, these associations were not confirmed in an independent analysis of 563 lower-grade glioma cases from the University of California at San Francisco Adult Glioma Study (p = 0.65 and p = 0.41, respectively). The results of this study do not support a role for inherited polymorphisms in myeloid-associated genes in affecting survival of patients diagnosed with glioblastoma or lower-grade glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Jacobs DI, Liu Y, Gabrusiewicz K, et al. Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients. J Neurooncol. 2017. PMID: 28965162. doi:10.1007/s11060-017-2622-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。